company background image
2422 logo

Sichuan Kelun Pharmaceutical XSEC:002422 Stock Report

Last Price

CN¥33.95

Market Cap

CN¥54.0b

7D

8.5%

1Y

6.3%

Updated

02 May, 2024

Data

Company Financials +

Sichuan Kelun Pharmaceutical Co., Ltd.

XSEC:002422 Stock Report

Market Cap: CN¥54.0b

Sichuan Kelun Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sichuan Kelun Pharmaceutical
Historical stock prices
Current Share PriceCN¥33.95
52 Week HighCN¥34.64
52 Week LowCN¥21.60
Beta0.043
1 Month Change14.23%
3 Month Change49.63%
1 Year Change6.29%
3 Year Change60.07%
5 Year Change22.65%
Change since IPO96.47%

Recent News & Updates

Recent updates

Shareholder Returns

2422CN PharmaceuticalsCN Market
7D8.5%5.6%3.1%
1Y6.3%-11.0%-13.1%

Return vs Industry: 002422 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.

Return vs Market: 002422 exceeded the CN Market which returned -13.1% over the past year.

Price Volatility

Is 2422's price volatile compared to industry and market?
2422 volatility
2422 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement7.5%
Market Average Movement8.6%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 002422's share price has been volatile over the past 3 months.

Volatility Over Time: 002422's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199619,798Sichuan Liuwww.kelun.com

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.

Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary

How do Sichuan Kelun Pharmaceutical's earnings and revenue compare to its market cap?
2422 fundamental statistics
Market capCN¥54.01b
Earnings (TTM)CN¥2.67b
Revenue (TTM)CN¥22.04b

20.2x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2422 income statement (TTM)
RevenueCN¥22.04b
Cost of RevenueCN¥10.49b
Gross ProfitCN¥11.55b
Other ExpensesCN¥8.88b
EarningsCN¥2.67b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.68
Gross Margin52.41%
Net Profit Margin12.11%
Debt/Equity Ratio19.7%

How did 2422 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.